-
A positive development on the
#biosimilars front. We need to do more to support a competitive biological marketplace that will help lower#healthcare costs. FDA and FTC vow to attack anti-competitive practices that limit biosimilar uptake https://www.statnews.com/pharmalot/2020/02/04/fda-ftc-biosimilars-anticompetitive/ … via@statnews -
Our latest STAT Report dives into the regulatory and manufacturing challenges
#biosimilars face — and possible solutions to bring them more success. Learn more here: https://buff.ly/2RBqFFr#pharma#STATReports -
FDA and FTC vow to attack anti-competitive practices that limit biosimilar uptake.. https://www.statnews.com/pharmalot/2020/02/04/fda-ftc-biosimilars-anticompetitive/ …
#pharma#biosimilars#antitrust -
What will it take to deliver on the promise of
#biosimilars in the U.S.? A new@statnews special report by@edsilverman answers this questions and takes a deep dive look into these life-saving therapies. Read the report now:https://bit.ly/36WjGLM -
The issue is not
#biosimilars@shandro, it's the forced switching of#IBD pts well managed on a#biologic. Decision was rushed and uninformed. Consequently, Albertans have many questions, are rightly upset and deserve so much more@jkenney#stoptheswitchhttp://bit.ly/3ah91OB -
Taking cue from the
@WHO revised list of#essential#medicines,#biosimilars for#cancer cure & treatments like#immunotherapy may get incorporated in India’s revised#NLEM, experts on oncology to meet today. https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/top-cancer-drugs-may-come-under-price-control/amp_articleshow/73131162.cms …pic.twitter.com/SH0dYeb0m1
-
'I don't want to regress': Patients, doctors divided on Alberta's move to change biologic drug coverage, by
@joeldryden https://www.cbc.ca/news/canada/calgary/remicade-tyler-shandro-remo-panaccione-janssen-moayyedi-1.5406328?__vfz=medium%3Dsharebar … via@cbccalgary#Remicade#biologics#biosimilarsPrikaži ovu nit -
@shandro is advancing the#biosimilars initiative, which will finally result in provincial insurance plan shifting patients to lower-cost and equally effective biosimilars. This is an important advance for patients, since savings can be deployed 1/2 https://www.theglobeandmail.com/canada/article-alberta-drug-plans-biosimilars-biologics-medications-arthritis-crohns/ …Prikaži ovu nit -
Alberta to become the second province in Canada to transition patients to
#biosimilars. @GoAHealth @shandrohttps://www.theglobeandmail.com/canada/article-alberta-drug-plans-biosimilars-biologics-medications-arthritis-crohns/ … -
#Biosimilars: "The major policy change in favour of the less-expensive versions, called biosimilars, will take effect by next summer and is expected to save $227-million to $380-million over the next four years." http://ow.ly/mBcl50xyj76 -
FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug
#FDA#Biosimilars#RheumatoidArthritishttp://feeds.reuters.com/~r/reuters/healthNews/~3/6NFgna0QlLs/fda-approves-amgens-biosimilar-to-jjs-rheumatoid-arthritis-drug-idUSKBN1YA230 … -
As of 2018,
#biosimilars accounted for 98% of the infliximab used in Norway, 92% in Britain, 78% in Sweden & 60% in France, according to @PMPRB_CEPMB. In Canada, that figure was 8%. Others argue a lack of#evidence to make a switch.@kellygrant1https://www.theglobeandmail.com/canada/article-drug-maker-urges-patients-to-speak-out-as-alberta-ontario-consider/ … -
#Biosimilars can offer patients more affordable and accessible options for biological therapies. But do we fully understand how they are manufactured, approved and regulated? Here's a comprehensive recap: http://ow.ly/XntB50wydTV -
Notable op-ed from
@peterbachmd in@WSJ: Time to Throw In the Towel on#Biosimilars. My $0.02: Too soon. Fix#340B (prices not in#ASP) and change#hospital incentives to jump start#PartB biosim market. OW, non-market interventions will get traction.https://drugch.nl/2KMA7m2 -
The great
#biosimilars war..An exclusive club for a breast cancer blockbuster in the US is turning into a crowded chamber. Roche's old horse#Herceptin is set to see newborns Amgen/Allergan, Biocon/Mylan, Celltrion/Teva, Samsung/Biogen & Pfizer...Read morehttps://prime.economictimes.indiatimes.com/news/70545589/pharma-and-healthcare/biocon-was-banking-big-on-its-breast-cancer-biosimilar-then-amgen-staged-an-ambush-can-it-bounce-back … -
B.C. Health Minister
@AdrianDix pleased that Health Canada taking 'corrective measures' with pharmaceutical company over pharma ads criticizing#biosimilars policy, by@MedicineMatters https://vancouversun.com/news/local-news/health-canada-taking-corrective-measures-with-pharmaceutical-company-over-pharma-ads/ … via@VancouverSun -
As an insurer with experience, Green Shield Canada
@GSC_1957 knows: “#Biosimilars are a prime example of that smart decision making that will ultimately protect the existence and viability of the Canadian health-care system.”#BecauseOfBiosimilarshttps://www.theglobeandmail.com/opinion/article-biosimilar-drugs-a-boon-to-be-applauded-as-they-provide-equivalent/ … -
Private insurer Green Shield Canada applauds B.C.’s
#biosimilar switching intitiative. “The decision to embrace#biosimilars is not a difficult one – it’s just logical.”@GSC_1957https://www.theglobeandmail.com/opinion/article-biosimilar-drugs-a-boon-to-be-applauded-as-they-provide-equivalent/ … -
Biosimilar drugs a boon to be applauded as they provide equivalent treatment at – sometimes – half the price https://www.theglobeandmail.com/opinion/article-biosimilar-drugs-a-boon-to-be-applauded-as-they-provide-equivalent/?utm_medium=Referrer:+Social+Network+/+Media&utm_campaign=Shared+Web+Article+Links … via
@GlobeDebate@jeffconnell29@GSC_1957#pharmacare#biosimilars -
There are
#biosimilars that have failed to launch due to patent litigation and patent related issues. New legislation by@SenatorCollins and@timkaine could help remedy this issue: http://bit.ly/2Pga5Ic pic.twitter.com/9aoheMqXvb
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.